Exercise alleviates Parkinsonism: clinical and laboratory evidence.
The present review examines the putative benefits for individuals afflicted with Parkinsonism, whether in the clinical setting or in the animal laboratory, accruing from different exercise regimes. The tendency for patients with Parkinson's disease (PD) to express either normal or reduced exercise capacity appears regulated by factors such as fatigue, quality-of-life and disorder severity. The associations between physical exercise and risk for PD, the effects of exercise on idiopathic Parkinsonism and quality-of-life, the effects of exercise on animal laboratory models of Parkinsonism and dopamine (DA) loss following neurotoxic insults, and the effects of exercise on the DA precursor, L-Dopa, efficacy are examined. It would appear to be case that in view of the particular responsiveness of the dopaminergic neurons to exercise, the principle of 'use it or lose' may be of special applicability among PD patients.
Department of Psychology, University of Gothenburg, Sweden. trevor.archer@psy.gu.se
T
T
Archer
A
A
Fredriksson
B
B
Johansson
D000818:Animals; D000978:Antiparkinson Agents / Q000627:therapeutic use; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism; D015444:Exercise / Q000502:physiology*; D005081:Exercise Therapy / Q000379:methods*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D009498:Neurotoxins / Q000633:toxicity; D020734:Parkinsonian Disorders / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism / Q000534:rehabilitation*; D011788:Quality of Life
D000978:Antiparkinson Agents; D009498:Neurotoxins; D007980:Levodopa; D004298:Dopamine